Skip to main content
Download PDF

Volume 2 Supplement 1

Metabolism, Diet and Disease 2014: Cancer and metabolism

  • Poster presentation
  • Open access
  • Published:

Human phosphoglycerate dehydrogenase produces the oncometabolite D-2-hydroxyglutarate and promotes histone methylation

Cancer & Metabolism volume 2, Article number: P75 (2014) Cite this article

Background

Human phosphoglycerate dehydrogenase (PHGDH), the first enzyme in the serine biosynthetic pathway, is genomically amplified in various tumors [1–3]. In such cells, PHGDH knockdown is not fully rescued by exogenous serine [2], suggesting possible additional roles for the enzyme.

Materials and methods

To analyze the catalytic activity of PHGDH on possible alternative substrates, we conducted in vitro biochemical assays on recombinant human PHGDH. The reaction rate in the reductive direction with various substrates was monitored based on NADH consumption, measured by absorbance at 340 nm. The identity and chirality of products were analyzed by liquid chromatography-mass spectrometry (LC-MS) and by gas chromatography-mass spectrometry (GC-MS) after (R)-2-butanol derivatization. To analyze the intracellular function of PHGDH, we generated stable PHGDH knockdown cell lines, using two shRNA sequences. Metabolite levels in the knockdown cells were analyzed by LC-MS [4], and DNA and histone methylation was analyzed by immunoblotting.

Results

Here we show that, in addition to catalyzing oxidation of 3-phosphoglycerate, PHGDH catalyzes NADH-dependent reduction of α-ketoglutarate to the oncometabolite D-2-hydroxyglutarate (D-2HG) and promotes histone methylation. The impact of PHGDH knockdown was studied in three cell lines with amplified PHGDH: MDA-MB-468, BT-20, and HCC70. Knockdown of PHGDH decreased 2HG levels in MDA-MB-468 and BT-20 cells, but not HCC70 cells (which had the highest 2HG levels of the three tested cell lines, with levels in MDA-MB-468 and BT-20 cells far below those found in cells with mutant IDH). These results suggest that PHGDH contributes to physiological 2HG pools, but may not produce high enough concentrations to cause pathology. Interestingly, in all three cell lines, PHGDH knockdown substantially decreased histone methylation. The mechanism underlying the decreased methylation upon PHGDH knockdown remains unclear, but it could be restored in MDA-MB-468 and BT-20 cells by addition of D-2HG ester.

Conclusion

PHGDH may promote histone methylation by mechanisms including 2-HG production.

References

  1. Mullarky E, Mattaini KR, Vander Heiden MG, Cantley LC, Locasale JW: PHGDH amplification and altered glucose metabolism in human melanoma. Pigment Cell Melanoma Res. 2011, 24: 1112-5. 10.1111/j.1755-148X.2011.00919.x.

    Article  CAS  PubMed  Google Scholar 

  2. Possemato R, et al: Functional genomics reveal that the serine synthesis pathway is essential in breast cancer. Nature. 2011, 476: 346-50. 10.1038/nature10350.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  3. Locasale JW, et al: Phosphoglycerate dehydrogenase diverts glycolytic flux and contributes to oncogenesis. Nat Genet. 2011, 43: 869-874. 10.1038/ng.890.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  4. Lu W, et al: Metabolomic analysis via reversed-phase ion-pairing liquid chromatography coupled to a stand alone orbitrap mass spectrometer. Anal Chem. 2010, 82: 3212-3221. 10.1021/ac902837x.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Lewis-Sigler Institute for Integrative Genomics and Department of Chemistry, Princeton University, Princeton, NJ, USA

    Jing Fan, Xin Teng, Ling Liu & Joshua Rabinowitz

  2. Department of Chemistry, University of Utah, Salt Lake City, UT, USA

    Ryan Looper

  3. Rutgers Cancer Institute of New Jersey, New Brunswick, NJ, USA

    Joshua Rabinowitz

Authors
  1. Jing Fan
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Xin Teng
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Ling Liu
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Ryan Looper
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Joshua Rabinowitz
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Open Access  This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made.

The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder.

To view a copy of this licence, visit https://creativecommons.org/licenses/by/4.0/.

The Creative Commons Public Domain Dedication waiver (https://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Fan, J., Teng, X., Liu, L. et al. Human phosphoglycerate dehydrogenase produces the oncometabolite D-2-hydroxyglutarate and promotes histone methylation. Cancer Metab 2 (Suppl 1), P75 (2014). https://doi.org/10.1186/2049-3002-2-S1-P75

Download citation

  • Published:

  • DOI: https://doi.org/10.1186/2049-3002-2-S1-P75

Keywords

Cancer & Metabolism

ISSN: 2049-3002